SEARCH

SEARCH BY CITATION

References

  • 1
    Bow EJ . Invasive fungal infection in haematopoietic stem cell transplant recipients: epidemiology from the transplant physician’s viewpoint . Mycopathologia 2009 ; 168 : 283297 .
  • 2
    Huang X , Liu D , Liu K et al. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for treatment of hematologic malignancies in children . Biol Blood Marrow Transplant 2009 ; 15 : 9194 .
  • 3
    Huang XJ , Liu DH , Liu KY et al. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies . Bone Marrow Transplant 2006 ; 38 : 291297 .
  • 4
    Lu DP , Dong L , Wu T et al. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation . Blood 2006 ; 107 : 30653073 .
  • 5
    Ascioglu S , Rex JH , de Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus . Clin Infect Dis 2002 ; 34 : 714 .
  • 6
    Przepiorka D , Weisdorf D , Martin P et al. 1994 consensus conference on acute GVHD grading . Bone Marrow Transplant 1995 ; 15 : 825828 .
  • 7
    Sullivan KM , Agura E , Anasetti C et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation . Semin Hematol 1991 ; 28 : 250259 .
  • 8
    Marr KA , Carter RA , Boeckh M , Martin P , Corey L . Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors . Blood 2002 ; 100 : 43584366 .
  • 9
    Aversa F , Reisner Y , Martelli MF . The haploidentical option for high-risk haematological malignancies . Blood Cells Mol Dis 2008 ; 40 : 812 .
  • 10
    Aversa F , Terenzi A , Tabilio A et al. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse . J Clin Oncol 2005 ; 23 : 34473454 .
  • 11
    Lang P , Greil J , Bader P et al. Long-term outcome after haploidentical stem cell transplantation in children . Blood Cells Mol Dis 2004 ; 33 : 281287 .
  • 12
    Jantunen E , Ruutu P , Niskanen L et al. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients . Bone Marrow Transplant 1997 ; 19 : 801808 .
  • 13
    Baddley JW , Stroud TP , Salzman D , Pappas PG . Invasive mold infections in allogeneic bone marrow transplant recipients . Clin Infect Dis 2001 ; 32 : 13191324 .
  • 14
    Kontoyiannis DP , Marr KA , Park BJ et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-associated Infection Surveillance Network (TRANSNET) database . Clin Infect Dis 2009 ; 50 : 10911100 .
  • 15
    Bolwell B , Pohlman B , Sobecks R et al. Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant . Bone Marrow Transplant 2004 ; 33 : 419423 .
  • 16
    Ramirez P , Brunstein CG , Miller B , Defor T , Weisdorf D . Delayed platelet recovery after allogeneic transplantation: a predictor of increased treatment-related mortality and poorer survival . Bone Marrow Transplant 2010 ; 46 : 981986 .
  • 17
    Kim DH , Baek JH , Kim JG et al. Clinical significance of platelet count at day +60 after allogeneic peripheral blood stem cell transplantation . J Korean Med Sci 2006 ; 21 : 4651 .
  • 18
    Kim DH , Sohn SK , Jeon SB et al. Prognostic significance of platelet recovery pattern after allogeneic HLA-identical sibling transplantation and its association with severe acute GVHD . Bone Marrow Transplant 2006 ; 37 : 101108 .
  • 19
    Chang YJ , Xu LP , Liu DH et al. Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status . Biol Blood Marrow Transplant 2009 ; 15 : 632638 .
  • 20
    Grazziutti ML , Rex JH , Cowart RE , Anaissie EJ , Ford A , Savary CA . Aspergillus fumigatus conidia induce a Th1-type cytokine response . J Infect Dis 1997 ; 176 : 15791583 .
  • 21
    Hebart H , Bollinger C , Fisch P et al. Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies . Blood 2002 ; 100 : 45214528 .
  • 22
    Cornely OA , Bohme A , Reichert D et al. Risk factors for breakthrough invasive fungal infection during secondary prophylaxis . J Antimicrob Chemother 2008 ; 61 : 939946 .
  • 23
    De Pauw B , Walsh TJ , Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group . Clin Infect Dis 2008 ; 46 : 18131821 .